李晨, 黄自琛, 刘文娜, 王疏桐, 李榕. 高龄冠心病患者预后影响因素[J]. 心脏杂志, 2023, 35(3): 274-278. DOI: 10.12125/j.chj.202211008
    引用本文: 李晨, 黄自琛, 刘文娜, 王疏桐, 李榕. 高龄冠心病患者预后影响因素[J]. 心脏杂志, 2023, 35(3): 274-278. DOI: 10.12125/j.chj.202211008
    Chen LI, Zi-chen HUANG, Wen-na LIU, Shu-tong WANG, Rong LI. A study on prognostic factors in elderly patients with coronary artery disease[J]. Chinese Heart Journal, 2023, 35(3): 274-278. DOI: 10.12125/j.chj.202211008
    Citation: Chen LI, Zi-chen HUANG, Wen-na LIU, Shu-tong WANG, Rong LI. A study on prognostic factors in elderly patients with coronary artery disease[J]. Chinese Heart Journal, 2023, 35(3): 274-278. DOI: 10.12125/j.chj.202211008

    高龄冠心病患者预后影响因素

    A study on prognostic factors in elderly patients with coronary artery disease

    • 摘要:
        目的   通过随访调查真实世界中高龄冠心病患者,分析影响其远期预后的主要危险因素。
        方法   分析2019年1月~2020年10月期间于空军军医大学西京医院住院治疗的高龄老年冠心病患者537例,按照治疗策略分为PCI组(n=439)和药物治疗组(n=98)。随访并比较两组出院后心源性死亡及主要不良心血管事件(MACE)发生情况,分析影响高龄冠心病长期不良预后的影响因素。
        结果  中位随访时间为34月,共计37例患者失访,药物治疗组9例(9%),PCI组28例(6%)。34例发生心源性死亡,其中药物治疗组4例(4%),PCI组30例(7%),但两组无统计学差异。多因素COX回归显示心源性死亡的危险因素为年龄、三支病变、房颤、左室射血分数(LVEF)<50%、ST段抬高型心肌梗死(STEMI);110例发生了MACE,其中药物治疗组17例(19%),PCI组93例(22%),两组无统计学差异。多因素COX回归分析MACE危险因素为贫血、三支病变、房颤。
        结论   研究提示,对三支病变、房颤和降低的LVEF进行积极干预,并改善贫血可能是降低高龄冠心病患者心源性死亡和MACE的重要治疗措施。

       

      Abstract:
        AIM  To analyze the real-world elderly patients with coronary artery disease (CAD) and explore the main risk factors affecting their long-term prognosis.
        METHODS  A retrospective study was performed in 537 elderly CAD patients hospitalized in Xijing Hospital of Air Force Medical University from January 2019 to October 2020. The patients were divided into PCI group (n=439) and drug treatment group (n=98). We followed up the patients and compared the cardiac death events and major adverse cardiovascular events (MACE) between the two groups. The influencing factors affecting the long-term adverse prognosis of coronary artery disease were analyzed.
        RESULTS  The median follow-up time was 34 months and 37 patients were lost to follow-up, among whom 9 cases (9%) were in drug treatment group and 28 cases (6%) in PCI group. In total, there were 34 cases of cardiac death, among whom 4 cases (4%) were in drug treatment group and 30 cases (7%) in PCI group, with no significant difference between the two groups. The risk factors for multivariate COX regression analysis showed that age, triple-vessel coronary artery disease (TVD), atrial fibrillation, left ventricular ejection fraction (LVEF)<50% and ST-elevation myocardial infarction (STEMI) were risk factors for cardiac death. In total, MACE occurred in 110 cases, with 17 cases (19%) in drug treatment group and 93 cases (22%) in PCI group. Multivariate COX regression analysis showed that anemia, TVD and atrial fibrillation were risk factors.
        CONCLUSION  The study suggests that active intervention in TVD and atrial fibrillation, reduced LVEF and improvement of anemia may be important therapeutic measures to reduce cardiac death and MACE in elderly patients with coronary artery disease.

       

    /

    返回文章
    返回